Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab

Rheumatology (Oxford). 2017 Apr 1;56(4):661-663. doi: 10.1093/rheumatology/kew493.

Authors

Diederik De Cock¹, Lucy Birmingham¹, Kath D Watson¹, Lianne Kearsley-Fleet¹; BSRBR Control Centre Consortium; Deborah P Symmons^{1

2}, Kimme L Hyrich^{1

2}

Affiliations

¹ Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre.
² National Institute of Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science, Manchester, UK.

PMID: 28137762
DOI: 10.1093/rheumatology/kew493

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antirheumatic Agents / adverse effects*
Arthritis, Rheumatoid / drug therapy*
Female
Humans
Pregnancy
Pregnancy Complications / drug therapy*
Pregnancy Outcome*
Registries
Rituximab / adverse effects*

Substances

Antirheumatic Agents
Rituximab

Grants and funding

20747/VAC_/Versus Arthritis/United Kingdom